• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Med Sci . Efficacy and Safety of Washed Microbiota Transplantation to Treat Patients with Mild-to-Severe COVID-19 and Suspected of Having Gut

tetano

Editor, Senior Moderator
  • Curr Med Sci
  • . 2021 Nov 30;1-9.
  • doi: 10.1007/s11596-021-2475-2. Online ahead of print.
  • Efficacy and Safety of Washed Microbiota Transplantation to Treat Patients with Mild-to-Severe COVID-19 and Suspected of Having Gut Microbiota Dysbiosis: Study Protocol for a Randomized Controlled Trial

Li-Hao Wu[SUP] #[/SUP][SUP] 1 2 [/SUP], Zhi-Ning Ye[SUP] #[/SUP][SUP] 1 2 [/SUP], Ping Peng[SUP] 3 [/SUP], Wen-Rui Xie[SUP] 1 2 [/SUP], Jia-Ting Xu[SUP] 1 2 [/SUP], Xue-Yuan Zhang[SUP] 1 2 [/SUP], Harry Hua-Xiang Xia[SUP] 1 [/SUP], Xing-Xiang He[SUP] 4 5 [/SUP]



Affiliations
Free PMC article

Abstract

Objective: Coronavirus disease 2019 (COVID-19) is often accompanied by gastrointestinal symptoms, which are related to gut microbiota dysbiosis (GMD). Whether washed microbiota transplantation (WMT) is an effective treatment for COVID-19 patients suspected of having GMD by restoring the gut microbiota is unknown. This study is designed to explore the efficacy and safety of WMT in COVID-19 patients suspected of having GMD.
Methods: This is a randomized, multicenter, single-blind prospective study. COVID-19 patients suspected of having GMD will be randomly divided to receive routine treatment only or to receive routine treatment and WMT. The frequency of WMT will be once a day for three consecutive days. Laboratory and imaging examinations will be performed at admission, 1 and 2 weeks after treatment, and on the day of discharge. Then a telephone follow-up will be conducted at 1st week, 2nd week, and 6th month after discharge. The clinical efficacy and safety of WMT in COVD-19 patients suspected of having GMD and the effects of WMT on the organ function, homeostasis, inflammatory response, intestinal mucosal barrier function, and immunity of the patients will be evaluated.
Results: By following the proposed protocol, WMT is expected to be efficacious and safe for the treatment of COVID-19 patients suspected of having GMD, and the therapeutic effect is expected to be associated with improvement of the intestinal mucosal barrier function, inflammatory response, and immunity.
Conclusion: The findings from this study may offer a new approach for the prevention and treatment of COVID-19 patients suspected of having GMD.

Keywords: COVID-19; SARS-Cov-2 virus; dysbiosis; gut microbiota; microbiome; washed microbiota transplantation.
 
Back
Top Bottom